Injection Ports vs. Single-Use Needles for Insulin in Pregnancy
This study is looking at whether using an injection port for insulin during pregnancy helps people take their insulin more regularly and feel better about their care. When you have diabetes during pregnancy, it's very important to keep blood sugar levels healthy, which often means many insulin shots each day. An injection port is a small device placed on your skin that lets you give insulin through the same spot without needing a new needle stick each time. This study wants to see if using an injection port (which is replaced about every 3 days) for two weeks, compared to using single-use needles for two weeks, improves how well you stick to your insulin plan and how satisfied you are. You might be able to join if you are a woman between 18 and 50 years old with type 2 diabetes or gestational diabetes who needs multiple insulin doses. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study with a planned enrollment of 44 participants. It compares two methods of insulin delivery: an injection port versus single-use insulin needles.
- What's involved
- Participants will use either an injection port or single-use needles for all insulin doses for two weeks. The injection port is inserted and replaced approximately every 3 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints, compliance with insulin administration and patient satisfaction, are measured at two weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lorie Harper · PRINCIPAL_INVESTIGATOR · University of Texas at Austin, Dell Medical School
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Compliance with insulin administrationTwo weeks
Patients' compliance with their insulin administration during each arm will be assessed by determining the total number of insulin doses that were missed.
- Patient satisfactionTwo weeks
Patients' satisfaction with each method of insulin administration will be determined used the Insulin Delivery Satisfaction Survey